Biotech Research Perceived With Caution Globally, but Most Support Gene Editing for TherapeuticsDecember 16, 2020
The global publics take a cautious stance towards scientific research on gene editing but draw distinctions for specific applications such as therapeutic use. This is according to the results of the International Science Survey conducted by Pew Research Center from October 2019 to March 2020.
The report is focused on the public perceptions of biotechnology, evolution, and the relationship between science and religion. The study was conducted amidst the fast development in biotechnology, particularly gene editing technology. About 63% (median) of the 20-public respondents say that gene editing is a misuse of technology. However, when asked about the use of technology to address serious diseases in infants, the majority said that the use of technology would be appropriate.
Furthermore, public opinions about the emerging applications of biotechnology are mixed. The majority of the publics surveyed expressed caution about the conduct of scientific research on gene editing and animal cloning. The respondents are generally in favor of gene editing applications in humans to reduce the risk of future health problems from occurring.Know more results from Pew Research.
You might also like:
- Genome Editing Resource
- Animal Biotech Offers Potential in Addressing Food Insecurity
- Gene Editing Used to Develop Vitamin A-fortified Rice
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- WHO Calls for Actions to Encourage Acceptance and Uptake of COVID-19 Vaccines
News from Around the World
- ISAAA Short Course Highlights Relevance of Integrating Research, Science-based Regulation, and SciCom in Sustainable Agri Dev't
- ISAAA Shares 2019 Global Biotech Crop Adoption to Stakeholders in the Philippines and Arab Region
- Give a Gift of Knowledge
- Webinar: Biotech Crop Adoption in 2019 and Latin America's Experience
- NBMA Validates National Biosafety Guidelines on Gene Editing in Nigeria
- University of Florida Study Uncovers Vanilla DNA Mystery
- RNAi Pesticides Could Be the Next Big Tool in Agriculture
- US FDA Has Approved First GM Pig for People with Red Meat Allergies
- Chinese Scientists Develop Rice Variety Using Ion Beam Technology
- GM Tomato Enriched with L-DOPA Offers Affordable Medicine for Parkinson's Disease
- Soybean Gene Overexpression Offers Resistance to SDS
Plant Breeding Innovations
- Biotech Research Perceived With Caution Globally, but Most Support Gene Editing for Therapeutics
Read the latest:
- Crop Biotech Update (October 5, 2022)
- Genome Editing Supplement (October 5, 2022)
- Gene Drive Supplement (September 28, 2022)
Subscribe to CBU: